摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-甲基-1H-苯并咪唑-2-羰酰氯 | 62366-45-4

中文名称
1-甲基-1H-苯并咪唑-2-羰酰氯
中文别名
1-甲基-1H-咪唑-2-羰酰氯
英文名称
1-methyl-1H-imidazole-2-carbonyl chloride
英文别名
1-methylimidazole-2-carbonyl chloride
1-甲基-1H-苯并咪唑-2-羰酰氯化学式
CAS
62366-45-4
化学式
C5H5ClN2O
mdl
MFCD04972638
分子量
144.56
InChiKey
FYAOUFIFNWYZQR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    275.1±23.0 °C(Predicted)
  • 密度:
    1.37±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    34.9
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    C
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R34
  • 海关编码:
    2933290090

SDS

SDS:83cb3ad34c3b7904aaaa2079a5380e95
查看
Name: 1-Methyl-1h-imidazole-2-carbonyl chloride 97% Material Safety Data Sheet
Synonym:
CAS: 62366-45-4
Section 1 - Chemical Product MSDS Name:1-Methyl-1h-imidazole-2-carbonyl chloride 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
62366-45-4 1-Methyl-1H-imidazole-2-carbonyl chlor 97% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 62366-45-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 67.7 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H5ClN2O
Molecular Weight: 144.56

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 62366-45-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Methyl-1H-imidazole-2-carbonyl chloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 62366-45-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 62366-45-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 62366-45-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-甲基-1H-苯并咪唑-2-羰酰氯 在 benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 、 sodium hydroxide 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 48.5h, 生成 4-[[1-Methyl-4-[[1-methyl-4-[(1-methylimidazole-2-carbonyl)amino]pyrrole-2-carbonyl]amino]pyrrole-2-carbonyl]amino]butanoic acid
    参考文献:
    名称:
    Synthesis and biophysical studies of hairpin polyamides targeting the Brn-3b and GATA-3 transcriptional sites
    摘要:
    Hairpin polyamide analogs of distamycin A (1) were designed and synthesized to evaluate their ability to bind 5'-ATAGA-3' and 5'-AGATA-3' sequences which are important elements for controlling the function of the Brn-3b and GATA-3 transcriptional factors, respectively. The hairpin polyamides are composed of pyrrole and imidazole units linked together via a.-aminobutyrate (GABA) unit. Hairpins 2b (Py-Py-Im-gamma-Py-Py-Py) and 2c (Im-Py-Py-gamma-Py-Py-Py) were synthesized to target the respective Brn-3b and GATA-3 cognate sequences. Preliminary biophysical studies including thermal denaturation and circular dichroism were performed and the results ascertained the binding of hairpins 2a and 2b to their respective cognate DNA sequences.
    DOI:
    10.1515/hc.2010.002
  • 作为产物:
    描述:
    参考文献:
    名称:
    带有 N-(1-alkyl-3-cyano-1H-indol-5-yl) 部分的酰胺基黄嘌呤氧化酶抑制剂:设计、合成和构效关系研究
    摘要:
    我们之前的工作确定了一种有前景的基于异烟酰胺的黄嘌呤氧化酶 (XO) 抑制剂N -(3-cyano-4-((2-cyanobenzyl)oxy)phenyl)isoicotinamide ( 1 ),并得出结论认为酰胺是探索完全不同于非布司他和托吡司他的五元环骨架的XO抑制剂化学空间。吲哚是一种内源性生物活性物质和流行的药物构建片段,参与了当前努力的结构优化活动。在安装了一些官能团后,生成了N -(1-alkyl-3-cyano-1 H -indol-5-yl) 并用于修复1的 3'-氰基之间缺失的 H 键相互作用和 XO 的 Asn768 残基通过缩短它们的距离。在此背景下,合理设计和合成了 8 种杂环芳香酰胺化学型,以研究酰胺基 XO 抑制剂的构效关系 (SAR)。优化后的化合物a6 (IC 50 = 0.018 μM) 的效力比初始化合物1 (IC 50  = 0.31 μM) 提高了
    DOI:
    10.1016/j.bioorg.2021.105417
点击查看最新优质反应信息

文献信息

  • IMIDAZOPYRIDINE COMPOUNDS
    申请人:Iwata Hidehisa
    公开号:US20100069431A1
    公开(公告)日:2010-03-18
    Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein.
    提供了用于与葡萄糖激酶一起使用的化合物、药物组合物、试剂盒和方法,其中包括从以下公式(I)所述的组中选择的化合物,其中变量如本文所定义。
  • A Mild Glycosylation Protocol with Glycosyl 1‐Methylimidazole‐2‐carboxylates as Donors
    作者:Jianpeng Chen、Yu Tang、Biao Yu
    DOI:10.1002/ejoc.202100677
    日期:2021.8.13
    A mild glycosylation protocol is developed by using glycosyl 1-methylimidazole-2-carboxylates as donors. Such a glycosylation can be promoted by a series of metal triflates and triflimides, especially Cu(OTf)2.
    通过使用糖基 1-methylimidazole-2-carboxylates 作为供体开发了温和的糖基化协议。这种糖基化可以通过一系列金属三氟甲磺酸酯和三氟甲磺酸酯,尤其是 Cu(OTf) 2来促进。
  • [EN] STEROIDAL [3, 2-C] PYRAZOLE COMPOUNDS, WITH GLUCOCORTICOID ACTIVITY<br/>[FR] COMPOSÉS [3, 2-C] PYRAZOLE STÉROÏDES À ACTIVITÉ GLUCOCORTICOÏDE
    申请人:ASTRAZENECA AB
    公开号:WO2009044200A1
    公开(公告)日:2009-04-09
    The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, X4, X5, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    本发明提供了式(I)的化合物,其中n、p、R1、R2、X1、X2、X3、X4、X5、R3a、R3b、R4、R5和R6的定义如规范中所述,以及它们的制备方法、含有它们的药物组合物以及它们在治疗中的应用。
  • A Common Diaryl Ether Intermediate for the Gram-Scale Synthesis of Oxazine and Xanthene Fluorophores
    作者:Andrew V. Anzalone、Tracy Y. Wang、Zhixing Chen、Virginia W. Cornish
    DOI:10.1002/anie.201205369
    日期:2013.1.7
    Common ground: Copper‐catalyzed coupling reactions can be used for the high‐yielding preparation of widely used oxazine and xanthene fluorophores from a common diaryl ether intermediate on a gram‐scale (see scheme). This general approach may facilitate the future development of novel fluorophores and probes with unique properties.
    共同点:铜催化的偶联反应可用于从常见的二芳基醚中间体以克级规模制备广泛使用的恶嗪和呫吨荧光团(参见方案)。这种通用方法可能有助于未来开发具有独特性质的新型荧光团和探针。
  • Asymmetric Construction of 2,3-Dihydroisoxazoles via an Organocatalytic Formal [3 + 2] Cycloaddition of Enynes with <i>N</i>-Hydroxylamines
    作者:Wenbo Li、Xiuzhao Yu、Zhenting Yue、Junliang Zhang
    DOI:10.1021/acs.orglett.6b01737
    日期:2016.8.19
    An organocatalytic asymmetric formal [3 + 2] cycloaddition of enynones with N-hydroxylamines has been described. A newly designed multifunctional organocatalyst was found to be highly effective, and the method allowed the synthesis of a variety of 2,3-dihydroisoxazoles in good yields with excellent enantioselectivity.
    已经描述了烯酮与N-羟胺的有机催化不对称的正式[3 + 2]环加成反应。发现一种新设计的多功能有机催化剂非常有效,该方法可以良好的收率和优异的对映选择性合成多种2,3-二氢异恶唑。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺